Skip to content

Apotheek Suys

Active
Private limited companyfounded 2004active for 22 yearsDorpsstraat 29, 9270 Laarne, BelgiumKBO/BCE: BE 0862.759.669
Summary

Apotheek Suys has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €180,908 and a net result of -€4,455. Equity is growing by about 3.1% per year across the filed financial years. Its solvency ranks better than 44% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€583,450total assets 2025
Staff
3.1 FTE
Equity
€180,908
Loss
-€4,455
Turnover not published (abbreviated format)
Financial health
89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Parent
SUYS INVEST · 100%
  • MenceDirector · permanent representative Morgane Suys
Accounts 38 days early1 of 5 deeds read
Why 89raises riskLoss of €4,455, the second in a row (financial year 2025)Sector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 1.60, cash €284,854Founded in 2004Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 46% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 56-1
equity 31.0% of total assets
Liquidity 72-3
short-term debt 54.9% · cash 48.8%
Profitability 31-4
return on assets -0.8%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,222 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025highest value 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026lowest value 08-2026: 0.2%● unchanged vs 07-2026lowest value 09-2026: 0.2%● unchanged vs 08-2026lowest value 10-2026: 0.2%● unchanged vs 09-2026lowest value
Credit of up to €16,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.6, compared with 1.69 in 2024, above the usual 1.5; short-term debt: 54.9% and cash: 48.8% of total assets), but 69% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 46% on solvency, 78% on liquidity, 25% on profitability and 34% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 1.60, cash €284,854
NBB · annual accounts
raises risk · Loss of €4,455, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 2004
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
38 days early
2024
98 days early
2023
16 days early
2022
11 days early
2021
22 days late
2020
61 days late
2019
52 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 4 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 16 July (4 of the last 5 filed years within 37 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: BV SUYS INVEST (director)Appointment: Mence BV (director) ·…
  2. Annual accounts filedfinancial year 2025 · abbreviated…
  3. Weakest financial yearnet -€4,455

Key points

  • Risk: 4 loss-making years in a rowloss financial year 2025 -€4,455 View
  • Caution: Board changedlatest change 14-08-2026 · 1 in office 1 joined · 1 left View
  • Controlled by SUYS INVEST 100% View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year
2025
Total assets
€583,450
Loss
-€4,455
Solvency
31.0%
Total assets▲ 0.5%
Net result
20182025
Go to Financials

Timeline

Events
26
Since
2005
Next accounts
by 31-07-2027
  1. 24-04-2025Annual accounts filed
  2. 15-07-2024Annual accounts filed
  3. 20-07-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
19-01-2004
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Apotheek Suys

What is the company number of Apotheek Suys?
0862.759.669. In Belgium the VAT number is the company number with BE in front: BE 0862.759.669.
Where is Apotheek Suys based?
The registered office is at Dorpsstraat 29, 9270 Laarne.Company details
What does Apotheek Suys do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Suys?
Private limited company (BV).
When was Apotheek Suys founded?
On 19-01-2004.
Is Apotheek Suys still active?
Yes, Apotheek Suys is an active enterprise in the KBO register.
How many employees does Apotheek Suys have?
On average 3.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Suys?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Apotheek Suys profitable?
In financial year 2025, Apotheek Suys made a loss of €4,455.
Where can I find the annual accounts of Apotheek Suys?
Apotheek Suys filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Suys due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Apotheek Suys

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.